[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"osteoarthritis-of-multiple-joints\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:osteoarthritis-of-multiple-joints":31},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":34,"overallStatus":39,"whyStopped":4,"lastUpdateSubmitDate":40,"lastUpdatePostDateStruct":41,"startDateStruct":44,"completionDateStruct":46,"leadSponsor":48,"locationsCount":51},"100380788","adipose-derived-biocellular-regenerative-therapy-for-osteoarthritis-100380788",false,"NCT04238143","Adipose-Derived Biocellular Regenerative Therapy for Osteoarthritis","Adipose-Derived Biocellular Regenerative Therapy in Treatment of Osteoarthritis (OA) and Associated Connective Tissue Degeneration and Pain","GARM-MSK-ALD","Inclusion Criteria:\n\n* Documented osteoarthritic inflammatory and\u002For degenerative changes in the joint or connective tissues of the knee, hip, shoulder, Achilles tendon, Sacroiliac Joint, wrist\u002Fhand, foot\u002Fankle, or Plantar Fasciitis (PR);\n* No systemic disorders which, in opinion of principal investigator, would disqualify from safely being able to undergo the determined procedures;\n* Have the ability to understand and accept all items in Informed Consent Document;\n* Have adequate perivascular and extracellular matrix donor tissues available;\n* Mature enough to tolerate determined procedures and follow up instructions and complete post-treatment tracking responsibilities\n\nExclusion Criteria:\n\n* Systemic or psychological impairment which would preclude patient tolerance and understanding nature and extent of procedures and follow up tracking;\n* Known active cancer, chemotherapy, or radiation therapy;\n* Pregnancy;\n* Active infections which would increase risk of patient to undergo treatment;\n* High dose steroid users, or recipients of corticosteroids with a six month period before treatment date;\n* Medication or Opiate addition, or in active treatment for drug rehabilitation;\n* History of documented severe traumatic brain injuries;\n* In the opinion of the principal investigator\u002Fprovider, the patient's condition or medical issues which would not allow the individual to fully accomplish or complete the study requirements","ALL","18 Years","90 Years",{"count":21,"type":22},100,"ESTIMATED","INTERVENTIONAL",[25],"NA","Use of Biocellular and cellular approaches to treatment of Osteoarthritis (OA), musculoskeletal aging processes, pain, and degenerative changes are to be studied with minimally invasive protocols, and non-pharmaceutical means to relieve OA and its associated issues. Traditional surgical interventions have not yielded convincing long-term outcomes, including total joint replacement surgeries and medical management of the supportive structures.\n\nThis study is to use a person's own stem\u002Fstromal Cells (autologous) plus HD-PRP (important healing growth factors and signal molecules) in such cases of OA for long-term minimally invasive treatments. Baseline (existing) findings are documented, and thence tracked as to progress deemed to be result of the intervention.",[28,29,30,31,32,33],"Osteoarthritis","Osteo Arthritis Knee","Osteo Arthritis Shoulders","Osteoarthritis of Multiple Joints","Osteoarthritis, Hip","Osteoarthritis - Ankle\u002FFoot",[35,36,37,38],"Arthritis","Degenerative","Joint Disease","Rheumatoid Arthritis","RECRUITING","2024-09-30",{"date":42,"type":43},"2024-10-01","ACTUAL",{"date":45,"type":43},"2020-01-10",{"date":47,"type":22},"2027-09-30",{"name":49,"class":50},"Healeon Medical Inc","INDUSTRY",2]